Italy seeks domestic production of mRNA COVID-19 vaccines - FT
- Country:
- Italy
Italy has held talks with several manufacturers about starting production of mRNA-based COVID-19 vaccines in the country, the Financial Times reported
Rome has discussed the domestic production of mRNA-based vaccines with Moderna Inc, Switzerland's Novartis AG, and Italy's ReiThera, the report added, citing people familiar with the matter.
ALSO READ
-
EIB and Intesa Sanpaolo Sign €300 Million Deal to Expand Affordable Housing in Italy
-
Italy and UN Partners Set Out Rome’s Growing Role as Global Development Finance Hub
-
Italy Mobilizes Navy to Secure Vital Shipping Lanes in Bab el-Mandeb
-
Italy Steps in as Final Stop for 2026 World Rally Championship
Google News